Why the study?
Does pyridostigmine reduce fatigue in subjects with postpoliomyelitis syndrome?
Does pyridostigmine reduce fatigue in subjects with postpoliomyelitis syndrome?
Pyridostigmine does not reduce fatigue in postpolio syndrome but may offer limited functional improvement in walking distance.
No takes yet. Share an insight, caveat, or question.
Pyridostigmine should not be used for fatigue in postpolio syndrome; extends evidence for modest walking gains requiring confirmation.
Herwin Horemans (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: